Moreover, C/EBPδ is downregulated in acute myeloid leukemia, cervical cancer and hepatocellular carcinoma, whereas epithelial C/EBPδ expression is also lost in PDAC patients [12,13,17]. Here, CEBPD is linked to cervical carcinoma.